Improving access to curative therapies for liver cancer in Black patients
Overcoming Racial Disparities in Curative Therapies for Hepatocellular Carcinoma
This study is working to help Black patients with liver cancer get better access to treatments by creating a new program called HCC-EduLink that will provide helpful education and support to navigate the healthcare system.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10885131 on NIH RePORTER |
What this research studies
This research focuses on addressing the significant disparities in access to curative therapies for hepatocellular carcinoma (HCC) among Black patients. It aims to develop and implement a new intervention called HCC-EduLink, which will utilize human-centered design methods to enhance patient education and navigation through the healthcare system. The project will involve randomized controlled trials to evaluate the effectiveness of these interventions in improving access to care. By understanding and addressing the social and structural factors that contribute to these disparities, the research seeks to create a more equitable healthcare environment for patients with liver cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black patients with chronic liver disease who are at risk for hepatocellular carcinoma.
Not a fit: Patients who are not Black or those who do not have chronic liver disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to life-saving treatments for Black patients diagnosed with hepatocellular carcinoma.
How similar studies have performed: Previous research has shown success in addressing health disparities through targeted interventions, indicating that this approach has potential for positive outcomes.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Nephew, Lauren — Indiana University Indianapolis
- Study coordinator: Nephew, Lauren
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.